These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7086702)

  • 1. Vancomycin in rabbits: pharmacokinetics, extravascular diffusion, renal excretion and interactions with furosemide.
    Nivoche Y; Contrepois A; Cremieux AC; Carbon C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):237-40. PubMed ID: 7086702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of furosemide on extravascular diffusion, protein binding and urinary excretion of cephalosporins and aminoglycosides in rabbits.
    Carbon C; Contrepois A; Vigneron AM; Lamotte-Barrillon S
    J Pharmacol Exp Ther; 1980 Jun; 213(3):600-6. PubMed ID: 7205620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of phenylbutazone on extravascular diffusion, protein binding and urinary excretion of cefazolin in rabbits.
    Carbon C; Contrepois A; Nivoche Y; Grandjean M; Decourt S; Chau NP
    J Pharmacol Exp Ther; 1981 Aug; 218(2):537-43. PubMed ID: 7252853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and extravascular diffusion of teicoplanin in rabbits and comparative efficacy with vancomycin in an experimental endocarditis model.
    Contrepois A; Joly V; Abel L; Pangon B; Vallois JM; Carbon C
    J Antimicrob Chemother; 1988 May; 21(5):621-31. PubMed ID: 2968969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
    Contrepois A; Daldoss C; Pangon B; Garaud JJ; Kecir M; Sarrazin C; Vallois JM; Carbon C
    J Antimicrob Chemother; 1984 Jul; 14(1):51-7. PubMed ID: 6384175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal disposition of ceftazidime illustrated by interferences by probenecid, furosemide, and indomethacin in rabbits.
    Carbon C; Dromer F; Brion N; Cremieux AC; Contrepois A
    Antimicrob Agents Chemother; 1984 Sep; 26(3):373-7. PubMed ID: 6391371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Furosemide renal excretion rate and the effects of the diuretic on different tubular sites are modified by endogenous dopamine in normohydrated rats.
    Nowicki S; Opezzo JA; Levin G; Gonzalez D; Elias MM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1348-54. PubMed ID: 7562507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion.
    Green TP; Mirkin BL
    J Pharmacol Exp Ther; 1981 Jul; 218(1):122-7. PubMed ID: 7241373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.
    Glew RH; Pavuk RA; Shuster A; Alfred HJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):559-63. PubMed ID: 7152738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of furosemide on the pharmacokinetics of benzylpenicillin and its penetration through the hematoencephalic barrier in experimental and clinical meningococcic meningitis].
    Ivanov KS; Verovaia AV; Popova NN; Tiurin AG
    Antibiotiki; 1977 Jun; 22(6):530-6. PubMed ID: 329749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of drugs in blood II. Unusual distribution and storage effect of furosemide.
    Lee MG; Chen ML; Chiou WL
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):17-28. PubMed ID: 7313302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
    Nowicki S; Levin G; Enero MA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1377-80. PubMed ID: 8450472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic interference between furosemide and cephalosporins].
    Iakovlev VP; Klimova VS; Em SV; Rudzit EA
    Antibiotiki; 1981 Apr; 26(4):287-90. PubMed ID: 7235669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diffusion of vancomycin in the cerebrospinal fluid, in the dog, in the absence of meningeal inflammation].
    Chabenat C; Moore N; Flipo JL; Barois A; Boismare F; Boucly P
    Pathol Biol (Paris); 1987 Nov; 35(9):1235-8. PubMed ID: 3320899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein binding studies of furosemide and penbutolol.
    Gottschalk R; Sistovaris N
    Arzneimittelforschung; 1985; 35(6):899-902. PubMed ID: 4026914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
    Gonzalez-Martin G; Acuna V; Perez C; Labarca J; Guevara A; Tagle R
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.